A Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer
by on Thursday, June 21st, 2012 | No Comments
Condition: Non-muscle Invasive Bladder Cancer
Intervention: Biological: ALT-801
Sponsors: Altor Bioscience Corporation; Altor Bioscience Corporation; Florida Department of Health James and Esther King Biomedical Research
Recruiting – verified June 2012
See more here: A Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer